Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients

Öncü M. R., Akta R. S., Gizli G., Bilvanisi S., Yildiz H., Baran A.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.26, sa.12, ss.4449-4455, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 12
  • Basım Tarihi: 2022
  • Doi Numarası: 10.26355/eurrev_202206_29084
  • Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.4449-4455
  • Anahtar Kelimeler: COVID-19, ABO blood groups, Comorbid diseases, Mortality
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

OBJECTIVE: This study aimed to investigate the mortality relationship between COVID-19 and ABO blood groups and comorbid diseases. The aim of this study was to determine whether ABO blood groups and comorbid diseases can be used as a prognostic factor for hospitalization.